Ivan A Zein

Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia

Ben Chih, Shirley Ng, Kenneth Shields, 2021, Nature Communications.

Praluzatamab Ravtansine, a CD166-Targeting Antibody–Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial

O. Vasiljeva, G. V. van Dongen, F. Meric-Bernstam, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.